BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16174538)

  • 1. Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks.
    Derkay C;
    Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1465-7. PubMed ID: 16174538
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
    Donne AJ; Rothera MP; Homer JJ
    Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic cidofovir in papillomatosis.
    Van Valckenborgh I; Wellens W; De Boeck K; Snoeck R; De Clercq E; Feenstra L
    Clin Infect Dis; 2001 Feb; 32(3):E62-4. PubMed ID: 11170974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
    Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
    Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cidofovir modulated gene expression in recurrent respiratory papillomatosis.
    Poetker DM; Patel NJ; Kerschner JE
    Int J Pediatr Otorhinolaryngol; 2008 Sep; 72(9):1385-92. PubMed ID: 18620760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
    Schraff S; Derkay CS; Burke B; Lawson L
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1039-42. PubMed ID: 15381589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
    Shehab N; Sweet BV; Hogikyan ND
    Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
    McMurray JS; Connor N; Ford CN
    Ann Otol Rhinol Laryngol; 2008 Jul; 117(7):477-83. PubMed ID: 18700421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir: to use or not to use?
    Soma MA; Albert DM
    Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
    Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
    Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
    J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
    Donne A; Rothera M; Homer J
    Clin Otolaryngol; 2010 Feb; 35(1):60. PubMed ID: 20447168
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
    Sahota RS; Uddin FJ; Al-Shukri J; Moir AA
    J Laryngol Otol; 2011 Apr; 125(4):402-4. PubMed ID: 21281536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
    Durvasula VS; Richter GT
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cidofovir for treatment of recurrent respiratory papillomatosis.
    Derkay C
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):198-201. PubMed ID: 19221249
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
    Donne AJ; Hampson L; He XT; Rothera MP; Homer JJ; Hampson IN
    Head Neck; 2007 Aug; 29(8):741-50. PubMed ID: 17252592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
    Lee AS; Rosen CA
    J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.
    Akst LM; Lee W; Discolo C; Knott D; Younes A; Koltai PJ
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):841-6. PubMed ID: 12925342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.